Those Bio-A cash figures were largely influenced by payment cycle of distributor (I rang to query them)
I don't see Bio-A in Australia being significant for SLA, for some time if at all.
Bio-A will only become significant (imo) if they can get it into some international health programmes eg for H.Porlori or for MRSA in hospitals.